 In the 7 o'clock hour, we're going to talk about the recent report looking at Ozempic, which is a diabetic drug. It's kind of become a weight loss drug, a weight loss phenomenon for America. And it looks at how Ozempic now has lowered the risk for some obesity-connected cancers. And so we're going to talk a little bit about that with a Yale doctor. Dr. Lustberg is going to join us in the 7 o'clock hour.